Celcuity Inc. (CELC) Fair Value 2026

CELC · Services-Medical Laboratories ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.8 /10

32 fundamental signals · 10 models active

Value Trap Risk

SAFE (18/100)

Quick Summary — As of 2026-07-15, Celcuity Inc. (CELC) trades at $91.51, approximately 200% above CirclFi’s Bayesian DCF fair value of $30.48. QOC: 4.8/10. Value Trap Risk: 18/100 (SAFE). 10/13 models active.

Key Facts

Ticker
CELC
Price
$91.51
Quality Score
4.8/10
Value Trap Risk
18/100
Models Active
10/13
Last Updated
Strength: First Chicago suggests +125.5% upside with 15% confidence
Risk: Below-average Quality Score of 4.8/10 signals weak fundamentals

Is Celcuity Inc. (CELC) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Celcuity Inc. (CELC) appears overvalued as of : the median of 10 independent fair value estimates is $48.70, 46.8% below the current price of $91.51. Estimates range from $0.19 to $206.40. CELC scores 4.8/10 on fundamental quality and 18/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Celcuity Inc. Stock in 2026? →

Valuation Matrix

10 Intrinsic Value Models vs. Current Price ($91.51)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $30.48 -66.7%
Earnings Power Value
High Conviction
 $54.23 -40.7%
CUCE Ensemble
Low Conviction
 $60.97 -33.4%
First Chicago
Low Conviction
 $206.40 +125.5%

Unlock the Full Matrix

Access 6 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is Celcuity Inc. (CELC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Celcuity Inc. at its current price of $91.51. The composite intrinsic value is estimated at $66.76 (-27.1% average return), with 7 models flagging overvaluation risk. The most optimistic model, First Chicago, places fair value at $206.40 (+125.5%), while ML-RIV — the most conservative — estimates $0.19 (-99.8%). This +225.3% gap reflects genuine analytical uncertainty about Celcuity Inc.'s intrinsic worth.

What Do the Models Say About CELC?

10 of 13 models are currently active for CELC. Of these, 3 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates CELC's intrinsic value at $30.48, implying -66.7% downside from the current price. See which stocks rank higher →

How Does CELC Rank in Services-Medical Laboratories?

Among 24 Services-Medical Laboratories stocks, CELC ranks #20 by Quality of Company score. CirclFi's QOC score of 4.8/10 evaluates 32 fundamental signals. A score of 4.8 reflects mixed fundamentals.

Celcuity Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CELC a Value Trap?

CirclFi's Value Trap algorithm assigns CELC a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Celcuity Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Celcuity Inc. is rated at 4.8/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

The gap between the most bullish and bearish model spans +225.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CELC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CELC's 10 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Celcuity Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Medical Laboratories Stocks Should You Also Analyze?

8 related Services-Medical Laboratories stocks with 13-model coverage

CSTLCastle Biosciences, Inc.QOC 9.2VCYTVeracyte, Inc.QOC 8.8DGXQuest Diagnostics IncorporatedQOC 8.3CDNACareDx, Inc.QOC 7.8FLGTFulgent Genetics, Inc.QOC 7.7LHLabcorp Holdings Inc.QOC 7.6RDNTRadNet, Inc.QOC 7.1XGNExagen Inc.QOC 7.0

Read investment analysis: CSTL · VCYT · DGX · CDNA · FLGT

Frequently Asked Questions About Celcuity Inc.

What is Celcuity Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Celcuity Inc. (CELC) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $30.48. The Quality of Company score is 4.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CELC overvalued or undervalued right now?

At $91.51, 3 of 10 active models suggest CELC may be undervalued, while 7 indicate potential overvaluation. The median of all 10 fair value estimates is $48.70, 46.8% below the current price of $91.51 — a consensus view that CELC is overvalued. The assessment depends on which methodology best fits Celcuity Inc.'s business model in Services-Medical Laboratories.

What does a Quality of Company score of 4.8 mean for CELC?

Celcuity Inc.'s QOC of 4.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on CELC?

CirclFi analyzes CELC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Is CELC a value trap in 2026?

Celcuity Inc.'s Value Trap score is 18/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Celcuity Inc. (CELC) has a median fair value of $48.70 — 46.8% below the current price of $91.51 — as of 2026-07-15.” Source: circlfi.com/stock/CELC/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on CELC.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access